Blood-Borne Diseases

A new study finds that some patients with sepsis who are discharged after initial treatment, and then seen through outpatient follow-up still have positive outcomes.

In sepsis patients undergoing CT imaging, contrast media administered intravenously does not significantly raise the risk of acute kidney infection.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

Two more states have reported hepatitis A outbreaks since our last update—here’s what you should know about them.

Rates of a lesser known virus related to HIV called HTLV-1 have surged in some of Australia’s Aboriginal communities, and now the country’s health officials are facing a global outcry to act.

A new report by Global Health Technologies Coalition assesses the economic impact of cuts to global health R&D on the economies of US states.

A recent study has found that a single-dose of Merck's Ebola vaccine delivers antibodies that can last for 1 to 2 years.

An outbreak of infections caused by the drug-resistant fungus, Candida auris, in one United Kingdom hospital has been linked to multi-use patient equipment.

If there are controlled substances at your facility, diversion is happening. What can be done to prevent future events?

Researchers present preliminary case series of confirmed cases of hepatitis A virus at Detroit Medical Center as Michigan struggles with ongoing outbreak.

Infections associated with the ongoing opioid epidemic in the United States apparently know no bounds.

Researchers have identified the OX40 pathway as playing a key role in viral clearance.

Unique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.

Invasive meningococcal disease doesn’t always present with the classic symptoms of stiff neck and headache—for a small subset of IMD patients, the abdomen is where the disease shows itself.

The risk comes after it was found that surgical instruments used for orthopedic and spine surgeries were not cleaned properly and consequently, the sterilization of those instruments was compromised.

The program can detect viral hemorrhagic fevers about 12 days faster than previous efforts.

The Global Virome Project is set to launch in 2018, and will spend the next 10 years working to identify as many as 827,000 unknown viruses in the wild.